安图生物 (603658)

Autobio Diagnostics Co., Ltd.

ASH

Tags

DeepSeekMSCI Mid Cap IndexSSE 380 IndexSSE Corporate Governance IndexArtificial Intelligence (AI)Pharmaceutical ManufacturingPharmaceuticals and HealthcareGene ConceptHelicobacter PyloriPrivate Enterprises 100 IndexBiological ProductsHigh-Performing StocksMargin Trading and Securities LendingMedical Devices医药生物

K-Line Chart

No K-line data available

Company NameZhengzhou Autobio Biotechnology Co., Ltd.
Listing Date2016-09-01
Issue Price14.58RMB
Registered Capital57142.476810k RMB
Legal RepresentativeYang Zengli
Registered AddressNo. 87 Jingbei 1st Road, Zhengzhou Economic and Technological Development Zone, Henan Province
IndustryMedical Devices
Main BusinessSpecialized in the R&D, production, and sales of in vitro diagnostic reagents and instruments
Company ProfileAutobio adheres to the corporate mission of 'committed to the popularization and improvement of medical laboratory technology, serving human health,' and strives to provide medical laboratories with products and services offering superior performance-to-price and quality-to-price ratios. Founded in 1998, Autobio focuses on the R&D, manufacturing, integration, and service of in vitro diagnostic reagents and instruments. Its products cover detection fields such as immunology, microbiology, and biochemistry, while also actively expanding into areas like molecular diagnostics, enabling it to provide comprehensive product solutions and overall services for medical laboratories. The company was listed on the Shanghai Stock Exchange on September 1, 2016, becoming the first in vitro diagnostic manufacturer listed on the Main Board in China. Autobio has established a nationally recognized enterprise technology center, a National-Local Joint Engineering Laboratory for Immunoassay Automation, and the Henan Provincial Engineering Research Center for Immunodiagnostic Reagents. It has undertaken numerous major national, provincial, and municipal science and technology projects, including two projects under the National High-Tech R&D Program (863 Program).

Stock Details

1. Key Indicators

  • Total Shares(W): 57142.48
  • Circulating A-Shares(W): 57142.48
  • Earnings Per Share(RMB): 1.5000
  • Net Assets Per Share(RMB): 15.3065
  • Operating Revenue(W RMB): 312715.62
  • Total Profit(W RMB): 95917.43
  • **Net Profit Attributable to Parent(W RMB) **: 85951.51
  • Net Profit Growth Rate(%): -10.11
  • Weighted Return on Equity(%): 9.8600
  • Operating Cash Flow Per Share(RMB): 1.4800
  • Undistributed Profit Per Share(RMB): 7.9148
  • Capital Reserve Per Share(RMB): 5.8768

2. Main Business

The main business covers:

  • Research, development, production and sales of in vitro diagnostic reagents and instruments

3. Company Basic Information

  • Company Name: Zhengzhou Autobio Biotechnology Co., Ltd.
  • Listing Date: 2016-09-01
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 87 Jingbei 1st Road, Zhengzhou Economic and Technological Development Zone, Henan Province
  • Website: https://www.autobio.com.cn/
  • Company Profile: The company was established through the overall transformation of Autobio Green Science and Technology, mainly engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhengzhou Autobio Industrial Group Co., Ltd. General Legal Person 32944.58 57.65
2 Z&F INTERNATIONAL TRADING LIMITED General Legal Person 7663.24 13.41
3 Zhonggeng Value Pioneer Stock Fund Fund 783.61 1.37
4 Hong Kong Securities Clearing Company Limited Northbound Capital 714.85 1.25
5 Huabao CSI Medical ETF Fund 483.37 0.85
6 Dacheng Ruixiang Mixed Fund Class A Fund 389.83 0.68
7 Dacheng Competitive Advantage Mixed Fund Class A Fund 276.11 0.48
8 Henan Tianbing Ice Cream Co., Ltd. General Legal Person 263.54 0.46
9 Zhonggeng Value Flexible Allocation Mixed Fund Fund 85.02 0.15
10 Dacheng Investment Strict Selection Six-Month Holding Mixed Fund Class A Fund 62.42 0.11

5. Concept Sectors

  • Gene Concept
  • Artificial Intelligence
  • Helicobacter Pylori
  • DeepSeek
  • Margin Trading
  • High-Performance Stocks
  • MSCI Mid Cap
  • SSE Governance
  • SSE 380
  • Private Enterprise 100

Remarks

  • Data update date: 2025-11-01
  • Data source: Public market information